-
1
-
-
0032483690
-
Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration
-
Detels R, Muñoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, Schrager LK, Phair JP. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. AIDS Cohort Study Investigators JAMA 1998, 280:1497-1503.
-
(1998)
AIDS Cohort Study Investigators JAMA
, vol.280
, pp. 1497-1503
-
-
Detels, R.1
Muñoz, A.2
McFarlane, G.3
Kingsley, L.A.4
Margolick, J.B.5
Giorgi, J.6
Schrager, L.K.7
Phair, J.P.8
-
2
-
-
0033537620
-
Improved survival among HIV infected patients after initiation of triple drug antiretroviral regimens
-
1230111, 10102000
-
Hogg RS, Yip B, Kully C, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS. Improved survival among HIV infected patients after initiation of triple drug antiretroviral regimens. CMAJ 1999, 160(Suppl 5):659-665. 1230111, 10102000.
-
(1999)
CMAJ
, vol.160
, Issue.SUPPL. 5
, pp. 659-665
-
-
Hogg, R.S.1
Yip, B.2
Kully, C.3
Craib, K.J.4
O'Shaughnessy, M.V.5
Schechter, M.T.6
Montaner, J.S.7
-
3
-
-
2642709177
-
Declining morbidity and mortality among patients with advanced human imunodeficiency virus infection. HIV outpatient Study Investigators
-
10.1056/NEJM199803263381301, 9516219
-
Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human imunodeficiency virus infection. HIV outpatient Study Investigators. N Engl J Med 1998, 338:853-860. 10.1056/NEJM199803263381301, 9516219.
-
(1998)
N Engl J Med
, vol.338
, pp. 853-860
-
-
Palella, F.J.1
Delaney, K.M.2
Moorman, A.C.3
Loveless, M.O.4
Fuhrer, J.5
Satten, G.A.6
Aschman, D.J.7
Holmberg, S.D.8
-
4
-
-
3242793170
-
Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV infected adults initiating protease inhibitor containing therapy
-
Antiprotease Cohort (APROCO) Study Group
-
Duval X, Journot V, Leport C, Chêne G, Dupon M, Cuzin L, May T, Morlat P, Waldner A, Salamon R, Raffi F, . Antiprotease Cohort (APROCO) Study Group Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV infected adults initiating protease inhibitor containing therapy. Infectious Dis Soc Am 2004, 39:248-255. Antiprotease Cohort (APROCO) Study Group.
-
(2004)
Infectious Dis Soc Am
, vol.39
, pp. 248-255
-
-
Duval, X.1
Journot, V.2
Leport, C.3
Chêne, G.4
Dupon, M.5
Cuzin, L.6
May, T.7
Morlat, P.8
Waldner, A.9
Salamon, R.10
Raffi, F.11
-
5
-
-
34848888307
-
Adverse effects of highly active antiretroviral therapy in developing countries
-
Subbaraman R, Chaguturu SK, Mayer KH, Flanigan TP, Kumarasamy N. Adverse effects of highly active antiretroviral therapy in developing countries. Clin Infectious Dis 2007, 45:1093-1101.
-
(2007)
Clin Infectious Dis
, vol.45
, pp. 1093-1101
-
-
Subbaraman, R.1
Chaguturu, S.K.2
Mayer, K.H.3
Flanigan, T.P.4
Kumarasamy, N.5
-
6
-
-
77954630522
-
Early versus standard antiretroviral therapy for HIV infected adults in Haiti
-
10.1056/NEJMoa0910370, 20647201
-
Patrice S, Juste MA, Ambroise A, Eliacin L, et al. Early versus standard antiretroviral therapy for HIV infected adults in Haiti. N Engl J Med 2010, 363:257-265. 10.1056/NEJMoa0910370, 20647201.
-
(2010)
N Engl J Med
, vol.363
, pp. 257-265
-
-
Patrice, S.1
Juste, M.A.2
Ambroise, A.3
Eliacin, L.4
-
7
-
-
12944265462
-
Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study
-
10.1097/00126334-200003010-00004, 10839659
-
Bonfanti P, Valsecchi L, Parazzini F, Carradori S, Pusterla L, et al. Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study. JAIDS 2000, 23:236-245. 10.1097/00126334-200003010-00004, 10839659.
-
(2000)
JAIDS
, vol.23
, pp. 236-245
-
-
Bonfanti, P.1
Valsecchi, L.2
Parazzini, F.3
Carradori, S.4
Pusterla, L.5
-
8
-
-
0037016386
-
Treatment of tuberculosis in HIV infected persons in the era of highly active antiretroviral therapy
-
10.1097/00002030-200201040-00010, 11741165
-
Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniak AL. Treatment of tuberculosis in HIV infected persons in the era of highly active antiretroviral therapy. AIDS 2002, 16:75-83. 10.1097/00002030-200201040-00010, 11741165.
-
(2002)
AIDS
, vol.16
, pp. 75-83
-
-
Dean, G.L.1
Edwards, S.G.2
Ives, N.J.3
Matthews, G.4
Fox, E.F.5
Navaratne, L.6
Fisher, M.7
Taylor, G.P.8
Miller, R.9
Taylor, C.B.10
de Ruiter, A.11
Pozniak, A.L.12
-
9
-
-
84859433967
-
Pharmacovigilance for antiretrovirals in resource poor countries. medicines policy and standards
-
World Health Organization
-
World Health Organization Pharmacovigilance for antiretrovirals in resource poor countries. medicines policy and standards. Geneva, World Health Organization 2007, World Health Organization.
-
(2007)
Geneva, World Health Organization
-
-
-
10
-
-
41449116953
-
Tolerability and effectiveness of first line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon
-
Laurent C, Bourgeois A, Mpoudi-Ngolé E, Ciaffi L, Kouanfack C, Mougnutou R, Nkoué N, Calmy A, Koulla-Shiro S, Delaporte E. Tolerability and effectiveness of first line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon. AIDS Res Human Retroviruses 2008, 24(Suppl 3):393-399.
-
(2008)
AIDS Res Human Retroviruses
, vol.24
, Issue.SUPPL. 3
, pp. 393-399
-
-
Laurent, C.1
Bourgeois, A.2
Mpoudi-Ngolé, E.3
Ciaffi, L.4
Kouanfack, C.5
Mougnutou, R.6
Nkoué, N.7
Calmy, A.8
Koulla-Shiro, S.9
Delaporte, E.10
-
11
-
-
0032419597
-
Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection
-
10.1016/S0149-2918(98)80105-7, 9916603
-
Pollard RB, Robinson P, Dransfield K. Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. Clin Ther 1998, 20:1071-1092. 10.1016/S0149-2918(98)80105-7, 9916603.
-
(1998)
Clin Ther
, vol.20
, pp. 1071-1092
-
-
Pollard, R.B.1
Robinson, P.2
Dransfield, K.3
-
12
-
-
77952822874
-
Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents
-
(DHHS), U. S. D. o. H. a. H. S
-
(DHHS), U. S. D. o. H. a. H. S Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Panel on antiretroviral guidelines for adults and adolescents 2006, (DHHS), U. S. D. o. H. a. H. S.
-
(2006)
Panel on antiretroviral guidelines for adults and adolescents
-
-
-
13
-
-
33750999624
-
British HIV association (BHIVA) guidelines for the treatment of HIV infected adults with antiretroviral therapy
-
Gazzard B, Bernard AJ, Boffito M, Churchill D, Edwards S, Fisher N, Geretti AM, Johnson M, Leen C, Peters B, Pozniak A, Ross J, Walsh J, Wilkins E, Youle M. British HIV association (BHIVA) guidelines for the treatment of HIV infected adults with antiretroviral therapy. HIV Med 2006, 7(Suppl 8):487-503.
-
(2006)
HIV Med
, vol.7
, Issue.SUPPL. 8
, pp. 487-503
-
-
Gazzard, B.1
Bernard, A.J.2
Boffito, M.3
Churchill, D.4
Edwards, S.5
Fisher, N.6
Geretti, A.M.7
Johnson, M.8
Leen, C.9
Peters, B.10
Pozniak, A.11
Ross, J.12
Walsh, J.13
Wilkins, E.14
Youle, M.15
-
14
-
-
27944510618
-
First-line antiretroviral therapy in Africa, how evidence based are our recommendations?
-
Colebunders R, Kamya MR, Laurence J, Kambugu A, Byakwaga H, Songa Mwebaze P, Muganzi Muganga A, Katwere M, Katabira E, Muganzi A. First-line antiretroviral therapy in Africa, how evidence based are our recommendations?. AIDS Rev 2005, 7(Suppl 3):148-154.
-
(2005)
AIDS Rev
, vol.7
, Issue.SUPPL. 3
, pp. 148-154
-
-
Colebunders, R.1
Kamya, M.R.2
Laurence, J.3
Kambugu, A.4
Byakwaga, H.5
Songa Mwebaze, P.6
Muganzi Muganga, A.7
Katwere, M.8
Katabira, E.9
Muganzi, A.10
-
15
-
-
1642578228
-
Adverse effects of antiretroviral therapy for HIV infection
-
Montessori V, Press N, Harris M, Akagi L, Montaner JSG. Adverse effects of antiretroviral therapy for HIV infection. Can Med Assoc Licensors 2004, 170(Suppl 2):229-238.
-
(2004)
Can Med Assoc Licensors
, vol.170
, Issue.SUPPL. 2
, pp. 229-238
-
-
Montessori, V.1
Press, N.2
Harris, M.3
Akagi, L.4
Montaner, J.S.G.5
-
16
-
-
34147115624
-
Antiretroviral associated toxicity among HIV 1 seropositive pregnant women in Mozambique receiving nevirapine based regimens
-
Jamisse L, Balkus J, Hitti J, Gloyd S, Manuel R, Osman N, Djedje M, Farquhar C. Antiretroviral associated toxicity among HIV 1 seropositive pregnant women in Mozambique receiving nevirapine based regimens. J Acquir Immune Defic Syndr 2007, 44(Suppl 4):371-376.
-
(2007)
J Acquir Immune Defic Syndr
, vol.44
, Issue.SUPPL. 4
, pp. 371-376
-
-
Jamisse, L.1
Balkus, J.2
Hitti, J.3
Gloyd, S.4
Manuel, R.5
Osman, N.6
Djedje, M.7
Farquhar, C.8
-
17
-
-
34547399409
-
Nevirapine associated toxicity in HIV-infected Thai men and women, including pregnant women
-
Phanuphak N, Apornpong T, Teeratakulpisarn S, Chaithongwongwatthana S, Taweepolcharoen C, Mangclaviraj S, Limpongsanurak S, Jadwattanakul T, Eiamapichart P, Luesomboon W, Apisarnthanarak A, Kamudhamas A, Tangsathapornpong A, Vitavasiri C, Singhakowinta N, Attakornwattana V, Kriengsinyot R, Methajittiphun P, Chunloy K, Preetiyathorn W, Aumchantr T, Toro P, Abrams EJ, El-Sadr W, Phanuphak P. Nevirapine associated toxicity in HIV-infected Thai men and women, including pregnant women. Br HIV Assoc 2007, 8:357-366.
-
(2007)
Br HIV Assoc
, vol.8
, pp. 357-366
-
-
Phanuphak, N.1
Apornpong, T.2
Teeratakulpisarn, S.3
Chaithongwongwatthana, S.4
Taweepolcharoen, C.5
Mangclaviraj, S.6
Limpongsanurak, S.7
Jadwattanakul, T.8
Eiamapichart, P.9
Luesomboon, W.10
Apisarnthanarak, A.11
Kamudhamas, A.12
Tangsathapornpong, A.13
Vitavasiri, C.14
Singhakowinta, N.15
Attakornwattana, V.16
Kriengsinyot, R.17
Methajittiphun, P.18
Chunloy, K.19
Preetiyathorn, W.20
Aumchantr, T.21
Toro, P.22
Abrams, E.J.23
El-Sadr, W.24
Phanuphak, P.25
more..
-
18
-
-
1542327563
-
Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors
-
Dieterich DT, Love J, Stern JO. Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors. Clin Infect Dis 2004, 38(Suppl 2):S80-S89.
-
(2004)
Clin Infect Dis
, vol.38
, Issue.SUPPL. 2
-
-
Dieterich, D.T.1
Love, J.2
Stern, J.O.3
-
19
-
-
1842614923
-
Hepatotoxicity associated with nevirapine use
-
10.1097/00126334-200404150-00014, 15021321
-
Baylor MS, Johann-Liang R. Hepatotoxicity associated with nevirapine use. J Acquir Immune Defic Syndr 2004, 35:538. 10.1097/00126334-200404150-00014, 15021321.
-
(2004)
J Acquir Immune Defic Syndr
, vol.35
, pp. 538
-
-
Baylor, M.S.1
Johann-Liang, R.2
-
20
-
-
0141681334
-
A comprehensive hepatic safety analysis of nevirapine in different populations of HIV-infected patients
-
10.1097/00126334-200309011-00005, 14562855
-
Stern JO, Robinson PA, Love J, Lanes S, Imperiale MS, Mayers DL. A comprehensive hepatic safety analysis of nevirapine in different populations of HIV-infected patients. J Acquir Immune Defic Syndr 2003, 34:S21-S33. 10.1097/00126334-200309011-00005, 14562855.
-
(2003)
J Acquir Immune Defic Syndr
, vol.34
-
-
Stern, J.O.1
Robinson, P.A.2
Love, J.3
Lanes, S.4
Imperiale, M.S.5
Mayers, D.L.6
-
21
-
-
0242333213
-
Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine containing antiretroviral treatment
-
10.1097/00002030-200310170-00009, 14523278
-
de Maat MM, ter Heine R, van Gorp EC, Mulder JW, Mairuhu AT, Beijnen JH. Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine containing antiretroviral treatment. AIDS 2003, 17:2209-2214. 10.1097/00002030-200310170-00009, 14523278.
-
(2003)
AIDS
, vol.17
, pp. 2209-2214
-
-
de Maat, M.M.1
ter Heine, R.2
van Gorp, E.C.3
Mulder, J.W.4
Mairuhu, A.T.5
Beijnen, J.H.6
-
22
-
-
0035816360
-
Hepatotoxicity in HIV infected patients recieving nevirapine containing antiretroviral therapy
-
10.1097/00002030-200107060-00007, 11426070
-
Martínez E, Blanco JL, Arnaiz JA, Pérez-Cuevas JB, Mocroft A, Cruceta A, Marcos MA, Milinkovic A, García-Viejo MA, Mallolas J, Carné X, Phillips A, Gatell JM. Hepatotoxicity in HIV infected patients recieving nevirapine containing antiretroviral therapy. AIDS 2001, 15:1261-1268. 10.1097/00002030-200107060-00007, 11426070.
-
(2001)
AIDS
, vol.15
, pp. 1261-1268
-
-
Martínez, E.1
Blanco, J.L.2
Arnaiz, J.A.3
Pérez-Cuevas, J.B.4
Mocroft, A.5
Cruceta, A.6
Marcos, M.A.7
Milinkovic, A.8
García-Viejo, M.A.9
Mallolas, J.10
Carné, X.11
Phillips, A.12
Gatell, J.M.13
-
23
-
-
84859426150
-
Hepatotoxicity associated with nevirapine or efavirenz containing antiretroviral therapy:role of hepatitis C and B infections
-
Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Hepatotoxicity associated with nevirapine or efavirenz containing antiretroviral therapy:role of hepatitis C and B infections. Hepatology 2003, 1:35.
-
(2003)
Hepatology
, vol.1
, pp. 35
-
-
Sulkowski, M.S.1
Thomas, D.L.2
Mehta, S.H.3
Chaisson, R.E.4
Moore, R.D.5
-
24
-
-
77952951784
-
The necessity for a health systems reform in Nigeria
-
Asuzu MC. The necessity for a health systems reform in Nigeria. J Community Med & Primary Health Care 2000, 16:1-3.
-
(2000)
J Community Med & Primary Health Care
, vol.16
, pp. 1-3
-
-
Asuzu, M.C.1
-
25
-
-
84892515307
-
National guidelines for HIV/AIDS treatment and care in adolescents and adults
-
Federal Ministry of Health Abuja, Nigeria
-
Federal Ministry of Health Abuja, Nigeria National guidelines for HIV/AIDS treatment and care in adolescents and adults. 2010, Federal Ministry of Health Abuja, Nigeria.
-
(2010)
-
-
-
26
-
-
84866663748
-
Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach
-
(accessed December 3rd, 2011), World Health Organization
-
World Health Organization Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. WHO 2006, 28. (accessed December 3rd, 2011), World Health Organization., http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf
-
(2006)
WHO
, pp. 28
-
-
-
27
-
-
84859423275
-
Assuring safety of preventive chemotherapy interventions for neglected tropical diseases. practical advice for national programme managers on the prevention, detection and management of serious adverse effects
-
(accessed December 3rd, 2011), World Health Organization
-
World Health Organization Assuring safety of preventive chemotherapy interventions for neglected tropical diseases. practical advice for national programme managers on the prevention, detection and management of serious adverse effects. WHO 2011, 1. (accessed December 3rd, 2011), World Health Organization., http://whqlibdoc.who.int/publications/2011/9789241502191_eng.pdf
-
(2011)
WHO
, pp. 1
-
-
-
28
-
-
77649173768
-
Longitudinal data analysis using generalized linear models
-
Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrica 1986, 73:13-22.
-
(1986)
Biometrica
, vol.73
, pp. 13-22
-
-
Liang, K.Y.1
Zeger, S.L.2
-
29
-
-
0027217429
-
Regression analysis for correlated data
-
Liang KY, Zeger SL. Regression analysis for correlated data. Annu Rev Publ Health 1993, 14:43-68.
-
(1993)
Annu Rev Publ Health
, vol.14
, pp. 43-68
-
-
Liang, K.Y.1
Zeger, S.L.2
-
30
-
-
84859433970
-
Glomerular dysfunction and associated risk factors following initiation of ART in adults with HIV infection in Africa [abstract THAB0105]
-
Reid A, Walker S, Ssali F, Munderi P, Gilks C. Glomerular dysfunction and associated risk factors following initiation of ART in adults with HIV infection in Africa [abstract THAB0105]. International AIDS Society 2006,
-
(2006)
International AIDS Society
-
-
Reid, A.1
Walker, S.2
Ssali, F.3
Munderi, P.4
Gilks, C.5
-
31
-
-
34147161191
-
Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda
-
Forna F, Liechty CA, Solberg P, Asiimwe F, Were W, Mermin J, Behumbiize P, Tong T, Brooks JT, Weidle PJ. Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr 2007, 44(Suppl 4):456-462.
-
(2007)
J Acquir Immune Defic Syndr
, vol.44
, Issue.SUPPL. 4
, pp. 456-462
-
-
Forna, F.1
Liechty, C.A.2
Solberg, P.3
Asiimwe, F.4
Were, W.5
Mermin, J.6
Behumbiize, P.7
Tong, T.8
Brooks, J.T.9
Weidle, P.J.10
-
33
-
-
0036545789
-
A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients
-
Idoko JA, Akinsete L, Abalaka AD, Keshinro LB, Dutse L, Onyenekwe B, Lhekwaba A, Njoku OS, Kehinde MO, Wambebe CO. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients. West Afr J Med 2002, 21:83-86.
-
(2002)
West Afr J Med
, vol.21
, pp. 83-86
-
-
Idoko, J.A.1
Akinsete, L.2
Abalaka, A.D.3
Keshinro, L.B.4
Dutse, L.5
Onyenekwe, B.6
Lhekwaba, A.7
Njoku, O.S.8
Kehinde, M.O.9
Wambebe, C.O.10
-
34
-
-
24044545281
-
Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Cô te d'Ivoire
-
Moh R, Danel C, Sorho S, Sauvageot D, Anzian A, Minga A, Gomis OB, Konga C, Inwoley A, Gabillard D, Bissagnene E, Salamon R, Anglaret X. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Cô te d'Ivoire. Antivir Ther 2005, 10:615-624.
-
(2005)
Antivir Ther
, vol.10
, pp. 615-624
-
-
Moh, R.1
Danel, C.2
Sorho, S.3
Sauvageot, D.4
Anzian, A.5
Minga, A.6
Gomis, O.B.7
Konga, C.8
Inwoley, A.9
Gabillard, D.10
Bissagnene, E.11
Salamon, R.12
Anglaret, X.13
-
35
-
-
33748125363
-
Adverse effects of antiretroviral therapy in HIV-1 infected children
-
Shah I. Adverse effects of antiretroviral therapy in HIV-1 infected children. J Trop Pediatr 2006, 52:244-248.
-
(2006)
J Trop Pediatr
, vol.52
, pp. 244-248
-
-
Shah, I.1
-
36
-
-
28244464827
-
Antiretroviral therapy in a thousand patients with AIDS in Haiti
-
10.1056/NEJMoa051908, 16319381
-
Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G, George E, Kenel-Pierre S, Wright PF, Gulick R, Johnson WD, Pape JW, Fitzgerald DW. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med 2005, 353:2325-2334. 10.1056/NEJMoa051908, 16319381.
-
(2005)
N Engl J Med
, vol.353
, pp. 2325-2334
-
-
Severe, P.1
Leger, P.2
Charles, M.3
Noel, F.4
Bonhomme, G.5
Bois, G.6
George, E.7
Kenel-Pierre, S.8
Wright, P.F.9
Gulick, R.10
Johnson, W.D.11
Pape, J.W.12
Fitzgerald, D.W.13
-
37
-
-
79952297768
-
Renal safety of tenofovir containing first line regimen: experience from an antiretroviral cohort in rural Lesotho
-
3047584, 21407815
-
Bygrave H, Kranzer K, Hilderbrand K, Jouquet G, Goemaere E, Vlahakis N, Triviño L, Makakole L, Ford N. Renal safety of tenofovir containing first line regimen: experience from an antiretroviral cohort in rural Lesotho. PLoS One 2011, 6(Suppl 3):e17609. 3047584, 21407815.
-
(2011)
PLoS One
, vol.6
, Issue.SUPPL. 3
-
-
Bygrave, H.1
Kranzer, K.2
Hilderbrand, K.3
Jouquet, G.4
Goemaere, E.5
Vlahakis, N.6
Triviño, L.7
Makakole, L.8
Ford, N.9
-
38
-
-
0033587510
-
Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions
-
Lucas GM, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med 1999, 131(Suppl 2):81-87.
-
(1999)
Ann Intern Med
, vol.131
, Issue.SUPPL. 2
, pp. 81-87
-
-
Lucas, G.M.1
Moore, R.D.2
-
39
-
-
57149111224
-
Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programs in resource-limited settings
-
Forster M, Bailey C, Brinkhof MWG. Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programs in resource-limited settings. Bull World Health Organization 2008, 86:939-947.
-
(2008)
Bull World Health Organization
, vol.86
, pp. 939-947
-
-
Forster, M.1
Bailey, C.2
Brinkhof, M.W.G.3
|